Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Roseiflexus castenholzii Probable cytosol aminopeptidase (pepA) CSB-YP418534RIP
CSB-EP418534RIP
CSB-BP418534RIP
CSB-MP418534RIP
CSB-EP418534RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Cobyric acid synthase (cobQ) CSB-YP418535RIP
CSB-EP418535RIP
CSB-BP418535RIP
CSB-MP418535RIP
CSB-EP418535RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii DNA ligase (ligA), partial CSB-YP418536RIP
CSB-EP418536RIP
CSB-BP418536RIP
CSB-MP418536RIP
CSB-EP418536RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Protein MraZ (mraZ) CSB-YP418537RIP
CSB-EP418537RIP
CSB-BP418537RIP
CSB-MP418537RIP
CSB-EP418537RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii UPF0272 protein Rcas_1165 (Rcas_1165) CSB-YP418538RIP
CSB-EP418538RIP
CSB-BP418538RIP
CSB-MP418538RIP
CSB-EP418538RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii UPF0234 protein Rcas_1283 (Rcas_1283) CSB-YP418539RIP
CSB-EP418539RIP
CSB-BP418539RIP
CSB-MP418539RIP
CSB-EP418539RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Phenylalanine--tRNA ligase alpha subunit (pheS) CSB-YP418540RIP
CSB-EP418540RIP
CSB-BP418540RIP
CSB-MP418540RIP
CSB-EP418540RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 3-isopropylmalate dehydratase small subunit (leuD) CSB-YP418541RIP
CSB-EP418541RIP
CSB-BP418541RIP
CSB-MP418541RIP
CSB-EP418541RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Tyrosine--tRNA ligase (tyrS) CSB-YP418542RIP
CSB-EP418542RIP
CSB-BP418542RIP
CSB-MP418542RIP
CSB-EP418542RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 50S ribosomal protein L27 (rpmA) CSB-YP418543RIP
CSB-EP418543RIP
CSB-BP418543RIP
CSB-MP418543RIP
CSB-EP418543RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii NADH-quinone oxidoreductase subunit A (nuoA), partial CSB-YP418544RIP1
CSB-EP418544RIP1
CSB-BP418544RIP1
CSB-MP418544RIP1
CSB-EP418544RIP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 4-hydroxy-2-oxovalerate aldolase (Rcas_2410) CSB-YP418545RIP
CSB-EP418545RIP
CSB-BP418545RIP
CSB-MP418545RIP
CSB-EP418545RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 60 kDa chaperonin 2 (groL2), partial CSB-YP418546RIP
CSB-EP418546RIP
CSB-BP418546RIP
CSB-MP418546RIP
CSB-EP418546RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii N utilization substance protein B homolog (nusB) CSB-YP418547RIP
CSB-EP418547RIP
CSB-BP418547RIP
CSB-MP418547RIP
CSB-EP418547RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii NADH-quinone oxidoreductase subunit K (nuoK), partial CSB-YP418548RIP1
CSB-EP418548RIP1
CSB-BP418548RIP1
CSB-MP418548RIP1
CSB-EP418548RIP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii UPF0173 metal-dependent hydrolase Rcas_3617 (Rcas_3617) CSB-YP418549RIP
CSB-EP418549RIP
CSB-BP418549RIP
CSB-MP418549RIP
CSB-EP418549RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Formamidopyrimidine-DNA glycosylase (mutM) CSB-YP418550RIP
CSB-EP418550RIP
CSB-BP418550RIP
CSB-MP418550RIP
CSB-EP418550RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii Imidazoleglycerol-phosphate dehydratase (hisB) CSB-YP418551RIP
CSB-EP418551RIP
CSB-BP418551RIP
CSB-MP418551RIP
CSB-EP418551RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 30S ribosomal protein S13 (rpsM) CSB-YP418552RIP
CSB-EP418552RIP
CSB-BP418552RIP
CSB-MP418552RIP
CSB-EP418552RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Roseiflexus castenholzii 30S ribosomal protein S17 (rpsQ) CSB-YP418553RIP
CSB-EP418553RIP
CSB-BP418553RIP
CSB-MP418553RIP
CSB-EP418553RIP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>